Correlation between antifungal susceptibilities of Coccidioides immitis in vitro and antifungal treatment with caspofungin in a mouse model

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 6, 2001, Pages 1854-1859

  González, Gloria M ^a,c   Tijerina, Rolando ^c   Najvar, Laura K ^a   Bocanegra, Rosie ^a   Luther, Michael ^a   Rinaldi, Michael G ^a,b   Graybill, John R ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^c UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; FLUCONAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COCCIDIOIDES IMMITIS; COCCIDIOSIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG SENSITIVITY; FUNGUS CULTURE; IN VITRO STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BODY BURDEN; CELLS, CULTURED; COCCIDIOIDES; COCCIDIOIDOMYCOSIS; MICE; MICROBIAL SENSITIVITY TESTS; MODELS, BIOLOGICAL; PEPTIDES; PEPTIDES, CYCLIC;

EID: 0343395859     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.6.1854-1859.2001     Document Type: Article

References (18)

1. Abruzzo, G. K., A. M. Flattery, C. J. Gill, L. Kong, J. G. Smith, V. B. Pikounis, J. M. Balkovec, A. F. Bouffard, J. F. Dropinski, H. Rosen, H. Kropp, and K. Bartizal. 1997. Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob. Agents Chemother. 41: 2333-2338.
2. Current, W. L., J. Tang, C. Boylan, P. Watson, D. Zeckner, W. Turner, M. Rodriguez, C. Dixon, D. Ma, and J. A. Radding. 1995. Glucan biosynthesis as a target for antifungals: the echinocandin class of antifungal agents, p. 143-157. In G. K. Dixon, L. G. Copping, and D. W. Hollomon (ed.), Antifungal agents, 1st ed. Bios Scientific Publishers, Oxford, United Kingdom.
3. Del Poeta, M., W. A. Schell, and J. R. Perfect. 1997. In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds. Antimicrob. Agents Chemother. 41:1835-1836.
4. De Lucca, A. J., and T. J. Walsh. 1999. Antifungal peptides: novel therapeutic compounds against emerging pathogens. Antimicrob. Agents Chemother. 43:1-11.
5. Galgiani, J. N., D. A. Stevens, J. R. Graybill, W. E. Dismukes, G. A. Cloud, and The NIAID Mycoses Study Group. 1988. Ketoconazole therapy of progressive coccidioidomycosis. Comparisons of 400- and 800-mg doses and observations at higher doses. Am. J. Med. 84:603-610.
6. Galgiani, J. N., S. H. Sun, K. V. Clemons, and D. A. Stevens. 1990. Activity of cilofungin against Coccidioides immitis: differential in vitro effects on mycelia and spherules correlated with in vivo studies. J. Infect. Dis. 162:944-948.
7. Gallis, H. A., R. H. Drew, and W. W. Pickard. 1990. Amphotericin B: 30 years of clinical experience. Rev. Infect. Dis. 12:308-329.
8. Graybill, J. R., D. A. Stevens, J. N. Galgiani, W. E. Dismukes, G. A. Cloud, and The NIAID Mycoses Study Group. 1990. Itraconazole treatment of coccidioidomycosis. Am. J. Med. 89:282-290.
9. Graybill, J. R., L. K. Najvar, M. F. Luther, and A. W. Fothergill. 1997. Treatment of murine disseminated candidiasis with L-743,872. Antimicrob. Agents Chemother. 41:1775-1777.
10. Graybill, J. R., L. K. Najvar, E. M. Montalbo, F. J. Barchiesi, M. F. Luther, and M. G. Rinaldi. 1998. Treatment of histoplasmosis with MK-991 (L-743,872). Antimicrob. Agents Chemother. 42:151-153.
11. Hall, G. S., C. Myles, K. J. Pratt, and J. A. Washington. 1988. Cilofungin (LY 121019), an antifungal agent with specific activity against Candida albicans and Candida tropicalis. Antimicrob. Agents Chemother. 32:1331-1335.
12. Hanson, L. H., and D. A. Stevens. 1989. Evaluation of cilofungin, a lipopeptide antifungal agent, in vitro against fungi isolated from clinical specimens. Antimicrob. Agents Chemother. 33:1391-1392.
13. Kurtz, M. B., I. B. Heath, J. Marrinan, S. Dreikron, J. Onishi, and C. Douglas. 1994. Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-β-D-glucan synthase. Antimicrob. Agents Chemother. 38:1480-1489.
14. Kurtz, M. B., and C. M. Douglas. 1997. Lipopeptide inhibitors of fungal glucan synthase. J. Med. Vet. Mycol. 35:79-86.
15. National Committee for Clinical Laboratory Standards. 1998. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi. Proposed standard. NCCLS document M38-P. National Committee for Clinical Laboratory Standards, Wayne, Pa.
16. Rinaldi, M. G. 1982. Use of potato flakes agar in clinical mycology. J. Clin. Microbiol. 15:1159-1160.
17. Stevens, D. A. 1995. Coccidioidomycosis. N. Engl. J. Med. 32:1077-1082.
18. Tucker, R. M., J. N. Galgiani, D. W. Denning, L. H. Hanson, J. R. Graybill, K. Sharkey, M. R. Eckman, C. Salemi, R. Libke, R. A. Klein, and D., A. Stevens. 1990. Treatment of coccidioidal meningitis with fluconazole. Rev. Infect. Dis. 12(Suppl. 3):S380-S389.